ISA 2020 | DISCOVERY: cardiac amyloidosis screening study

Mathew Maurer, MD, Columbia University, New York, NY, discusses the results of the DISCOVERY screening study (NCT02252653), which investigated the prevalence of TTR mutations in patients suspected of having cardiac amyloidosis. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).